HEDS is part of the School of Health and Related Research (ScHARR) at the University of Sheffield. We undertake research, teaching, training and consultancy on all aspects of health related decision science, with a particular emphasis on health economics, HTA and evidence synthesis.

Thursday, 23 June 2011

Recent CUAs

Twice each month the CEA Registry Blog lists recently published cost utility studies and associated papers. 30 papers were listed this time. Here's a handful in our areas of our research interest:

Crespin DJ, Federspiel JJ, Biddle AK, et al. Ticagrelor versus Genotype-Driven Antiplatelet Therapy for Secondary Prevention after Acute Coronary Syndrome: A Cost-Effectiveness Analysis. Value Health. 2011 Jun;14(4):483-91. Epub 2011 May 19. PubMed PMID: 21669373.

Hayes AJ, Clarke PM, Voysey M, Keech A. Simulation of Quality-Adjusted Survival in Chronic Diseases: An Application in Type 2 Diabetes. Med Decis Making. 2011 Jun 2. [Epub ahead of print] PubMed PMID: 21636740.

Woodhall SC, Jit M, Soldan K, et al; on behalf of the QOLIGEN study group. The impact of genital warts: loss of quality of life and cost of treatment in eight sexual health clinics in the UK. Sex Transm Infect. 2011 Jun 2. [Epub ahead of print] PubMed PMID: 21636616.

Biggs SA, Duarte RV, Raphael JH, et al. Influence of a latent period in QALY anaylsis: Pilot study of intrathecal drug delivery systems for chronic non-malignant pain. Br J Neurosurg. 2011 Jun;25(3):401-6. Epub 2011 Feb 28. PubMed PMID: 21355772.

Kondo M, Hoshi SL, Yamanaka T, et al. Economic evaluation of the 21-gene signature (Oncotype DX(®)) in lymph node-negative/positive, hormone receptor-positive early-stage breast cancer based on Japanese validation study (JBCRG-TR03). Breast Cancer Res Treat. 2011 Jun;127(3):739-49. Epub 2010 Nov 17.  PubMed PMID: 21082239.